← Leaderboards
Gustavo Walter Leone
Ohio State University
$13,862,104
Attributed
$13,862,104
Total exposure
8
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.9M · FY2005–23$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$19,110,473 · 9
By mechanism
P30$9,447,196 · 3
R01$6,898,268 · 4
P01$2,765,009 · 2
Top collaborators
No co-investigators on record.
Most similar at Ohio State University
Same institution · by research overlap
- Matthew D Ringel$21,305,885
- Patrick Lee Green$10,720,230
- Electra D. Paskett$38,729,537
- Michael D Lairmore$5,085,750
- Michael C Ostrowski$13,472,116
Others in their field
Top investigators on “Programs”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,641,009,751
- Leonard Freedman · Leidos Biomedical Research, Inc.$994,984,644
- Lawrence Corey · Fred Hutchinson Cancer Center$730,186,538
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Larry Arthur$609,313,548
Research focus
ProgramsMalignant NeoplasmsTumor Suppressor ProteinsTranscription FactorMolecularApoptosisCell ProliferationCellsUniversitiesGene ExpressionTechnologyCancer Center Support GrantMedicalSouth CarolinaInterdisciplinary CollaborationScientistCancer CenterBaseGeneticGenesGene TargetingLaboratory MouseLaboratoriesCharge
Grant awards (58)
Developmental Funds$581,092
P30 · FY2023 · CA · contact PI
Leadership, Planning, and Evaluation$264,207
P30 · FY2023 · CA · contact PI
Developmental Funds$581,092
P30 · FY2022 · CA · contact PI
Leadership, Planning, and Evaluation$264,207
P30 · FY2022 · CA · contact PI
Developmental Funds$581,092
P30 · FY2021 · CA · contact PI
Leadership, Planning, and Evaluation$264,207
P30 · FY2021 · CA · contact PI
Developmental Funds$581,092
P30 · FY2020 · CA · contact PI
Leadership, Planning, and Evaluation$264,207
P30 · FY2020 · CA · contact PI
Developmental Funds$562,072
P30 · FY2019 · CA · contact PI
Leadership, Planning, and Evaluation$255,559
P30 · FY2019 · CA · contact PI
Medical University of South Carolina - Cancer Center Support Grant$115,000
P30 · FY2019 · CA · contact PI
Medical University of South Carolina - Cancer Center Support Grant$104,100
P30 · FY2019 · CA · contact PI
Medical University of South Carolina - Cancer Center Support Grant$2,093,000
P30 · FY2018 · CA · contact PI
Tumor suppressor roles of E2F7 & E2F8 in hepatocellular carcinoma$295,681
R01 · FY2018 · CA · contact PI
Medical University of South Carolina - Cancer Center Support Grant$249,843
P30 · FY2018 · CA · contact PI
Medical University of South Carolina - Cancer Center Support Grant$20,000
P30 · FY2018 · CA · contact PI
Medical University of South Carolina - Cancer Center Support Grant$2,093,000
P30 · FY2017 · CA · contact PI
Tumor suppressor roles of E2F7 & E2F8 in hepatocellular carcinoma$271,221
R01 · FY2017 · CA · contact PI
Medical University of South Carolina - Cancer Center Support Grant$214,283
P30 · FY2017 · CA · contact PI
Medical University of South Carolina - Cancer Center Support Grant$145,743
P30 · FY2017 · CA · contact PI
Medical University of South Carolina - Cancer Center Support Grant$112,498
P30 · FY2017 · CA · contact PI
Medical University of South Carolina - Cancer Center Support Grant$100,902
P30 · FY2017 · CA · contact PI
Tumor Suppressor Roles of E2F7 & E2F8 in Hepatocellular Carcinoma (HCC)$316,102
R01 · FY2016 · CA · contact PI
Suppression of Mammary Tumorigenesis by Stromal p53$299,187
P01 · FY2016 · CA · contact PI
Tumor Suppressor Roles of E2F7 & E2F8 in Hepatocellular Carcinoma (HCC)$331,382
R01 · FY2015 · CA · contact PI
Suppression of Mammary Tumorigenesis by Stromal p53$299,187
P01 · FY2015 · CA · contact PI
Tumor Suppressor Roles of E2F7 & E2F8 in Hepatocellular Carcinoma (HCC)$346,219
R01 · FY2014 · CA · contact PI
Suppression of Mammary Tumorigenesis by Stromal p53$290,212
P01 · FY2014 · CA · contact PI
Suppression of Mammary Tumorigenesis by Stromal p53$281,241
P01 · FY2013 · CA · contact PI
E2F7 & E2F8 in the control of transcription and cellular proliferation$301,913
R01 · FY2012 · CA · contact PI
Suppression of Mammary Tumorigenesis by Stromal p53$301,062
P01 · FY2012 · CA · contact PI
E2F7 & E2F8 in the control of transcription and cellular proliferation$301,913
R01 · FY2011 · CA · contact PI
E2F7 & E2F8 in the control of transcription and cellular proliferation$311,250
R01 · FY2010 · CA · contact PI
E2F7 & E2F8 in the control of transcription and cellular proliferation$311,250
R01 · FY2009 · CA · contact PI
Rb & E2Fs Regulating Stromal/Epithelial Interactions during Breast Carcinogenesis$342,080
P01 · FY2008 · CA · contact PI
E2F7 & E2F8 in the control of transcription and cellular proliferation$311,250
R01 · FY2008 · CA · contact PI
E2F3 and embryonic development$308,384
R01 · FY2008 · HD · contact PI
Rb & E2Fs Regulating Stromal/Epithelial Interactions during Breast Carcinogenesis$338,621
P01 · FY2007 · CA · contact PI
E2F3 and embryonic development$314,678
R01 · FY2007 · HD · contact PI
E2F3 and embryonic development$324,077
R01 · FY2006 · HD · contact PI
Role of Rb and E2Fs in Regulating Stromal/Epithelial$207,731
P01 · FY2006 · CA · contact PI
E2F3 and embryonic development$322,375
R01 · FY2005 · HD
E2F3 GENE LOCUS IN THE CONTROL OF CELL PROLIFERATION$232,313
R01 · FY2005 · CA
Role of Rb and E2Fs in Regulating Stromal/Epithelial$201,682
P01 · FY2005 · CA
E2F3 and embryonic development$331,875
R01 · FY2004 · HD
E2F3 GENE LOCUS IN THE CONTROL OF CELL PROLIFERATION$232,313
R01 · FY2004 · CA
Role of Rb and E2Fs in Regulating Stromal/Epithelial$204,006
P01 · FY2004 · CA
E2F3 GENE LOCUS IN THE CONTROL OF CELL PROLIFERATION$232,313
R01 · FY2003 · CA
E2F AND THE CONTROL OF APOPTOSIS$201,550
R01 · FY2003 · CA
E2F3 GENE LOCUS IN THE CONTROL OF CELL PROLIFERATION$67,850
R01 · FY2003 · CA
E2F3 GENE LOCUS IN THE CONTROL OF CELL PROLIFERATION$231,919
R01 · FY2002 · CA
E2F AND THE CONTROL OF APOPTOSIS$195,677
R01 · FY2002 · CA
E2F3 GENE LOCUS IN THE CONTROL OF CELL PROLIFERATION$67,735
R01 · FY2002 · CA
E2F3 GENE LOCUS IN THE CONTROL OF CELL PROLIFERATION$231,525
R01 · FY2001 · CA
E2F AND THE CONTROL OF APOPTOSIS$207,402
R01 · FY2001 · CA
E2F3 GENE LOCUS IN THE CONTROL OF CELL PROLIFERATION$62,720
R01 · FY2001 · CA
E2F AND THE CONTROL OF APOPTOSIS$201,362
R01 · FY2000 · CA
E2F AND THE CONTROL OF APOPTOSIS$34,019
R01 · FY2000 · CA